PuSH - Publikationsserver des Helmholtz Zentrums München

Wanner, C.* ; Cosentino, F.* ; Barnard-Kelly, K.* ; Battelino, T.* ; Blüher, M. ; Boll, H.N.* ; Brosius, F.C.* ; Busetto, L.* ; Ceriello, A.* ; Gavin, J.R.* ; Giorgino, F.* ; Green, J.* ; Ji, L.* ; Kellerer, M.* ; Koob, S.* ; Lalic, N.* ; Marx, N.* ; Nedungadi, P.* ; Parkin, C.G.* ; Rodbard, H.W.* ; Rydén, L.* ; Saboo, B.* ; Sheu, W.H.* ; Standl, E.* ; Tacke, F.* ; Topsever, P.* ; Schnell, O.*

From global guidelines for cardio-kidney-metabolic diseases management to national implementation: Perspectives from the guideline workshop taskforce.

Cardiovasc. Diabetol. 25:66 (2026)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
International guidelines define standards of care for type 2 diabetes (T2D), obesity, cardiovascular disease (CVD), metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD). Yet implementation at the national level remains inconsistent, leading to persistent gaps between evidence-based recommendations and real-world practice. Key barriers include linguistic and cultural adaptation, limited communication to clinicians, and siloed regulatory and reimbursement processes. Addressing these challenges requires coordinated strategies, such as concise translations, digital platforms and decision-support tools, integration into medical education, and structured monitoring and evaluation frameworks with feedback and incentives. Equitable and sustainable access further depends on coordination between medical societies, governmental authorities, payers, and patient representatives. Evidence from existing initiatives shows that systematic, context-sensitive approaches can measurably improve care. Building on these lessons, this Commentary recommends priorities for national implementation to ensure that guidelines move more effectively from publication to practice and realise their full potential to improve patient outcomes.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Cardiovascular Disease ; Chronic Kidney Disease ; Clinical Practice Guideline Implementation ; Diabetes ; Obesity; Heart-association; European-society; Health-care; Performance; Risk; Pay
ISSN (print) / ISBN 1475-2840
e-ISSN 1475-2840
Quellenangaben Band: 25, Heft: 1, Seiten: , Artikelnummer: 66 Supplement: ,
Verlag Springer
Verlagsort Campus, 4 Crinan St, London N1 9xw, England
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
Förderungen Eli Lilly and Company
Dexcom, Inc.
Bayer AG
AstraZeneca Pharmaceuticals LP